Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980 Feb 16;280(6212):442-4.
doi: 10.1136/bmj.280.6212.442.

Sulphasalazine in rheumatoid arthritis

B McConkey, R S Amos, S Durham, P J Forster, S Hubball, L Walsh

Sulphasalazine in rheumatoid arthritis

B McConkey et al. Br Med J. .

Abstract

Seventy-four patients with rheumatoid arthritis were treated with sulphasalazine. There was a significant improvement in clinical score, with substantial falls in serum C-reactive protein concentrations and erythrocyte sedimentation rate four weeks after starting the drug. Improvement was maintained in the 38 patients who remained on the drug for one year. The mean Rose-Waaler titre did not change. There was little difference between the results in seropositive and seronegative patients. The commonest adverse effect was dyspepsia, but five patients developed a megaloblastic anaemia and one patient neutropenia; all made a complete recovery. The results suggest that the drug has a disease-modifying action not attributable to its "salicylate" content. The mode of action might be by an antibacterial effect on gut flora.

PubMed Disclaimer

References

    1. Q J Med. 1972 Apr;41(162):115-25 - PubMed
    1. Gut. 1974 Dec;15(12):960-5 - PubMed
    1. Ann Rheum Dis. 1979 Apr;38(2):141-4 - PubMed
    1. Ann Rheum Dis. 1949 Sep;8(3):226-31 - PubMed
    1. Agents Actions. 1978 Jun;8(4):438-41 - PubMed